Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open Phase 1B Study for Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Oxaliplatin-based Chemotherapy in Patients With Gastro-intestinal Malignancies

Next Previous
X
Search
Trial Profile

An Open Phase 1B Study for Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Oxaliplatin-based Chemotherapy in Patients With Gastro-intestinal Malignancies

Status: Discontinued
Phase of Trial: Phase I

Latest Information Update: 19 Sep 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; PL MLP (Primary)
  • Indications Adenocarcinoma; Carcinoma; Cholangiocarcinoma; Colorectal cancer; Endocrine gland neoplasms; Gallbladder cancer; Gastric cancer; Gastrointestinal cancer; Oesophageal cancer; Pancreatic cancer; Rectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Lipomedix Pharmaceuticals

    • Most Recent Events

    • 12 Sep 2023 Status changed from active, no longer recruiting to discontinued.
    • 21 Dec 2022 Planned End Date changed from 1 Nov 2022 to 1 May 2023.
    • 21 Dec 2022 Planned primary completion date changed from 1 Sep 2022 to 1 Mar 2023.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top